Massimo Amelotti
Impact in
-
- COVID-19 Clinical Research Studies
-
- Acute Kidney Injury Research
Papers in
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 5
- Immune Cell Function and Interaction 1
-
- Monoclonal and Polyclonal Antibodies Research 3
- Co-authors
- Franco Dallegri (7 shared papers)Luciano Carlo Ottonello (7 shared papers)Giuseppe Tortolina (2 shared papers)Patrizia Dapino (5 shared papers)Maria Bianca Bertolotto (1 shared paper)Paola Contini (1 shared paper)Clemente Mazzei (1 shared paper)Francesco Indiveri (1 shared paper)
- Journals
- Inflammation Research (2 papers)Blood (1 paper)Clinical Microbiology and Infection (1 paper)Journal of Leukocyte Biology (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- ItalyUnited States
In The Last Decade
Massimo Amelotti
9 papers receiving 370 citations
Peers
Comparison fields: 5 of 55
- Infectious Diseases 88
- Nephrology 40
- Immunology 71
- Biochemistry 21
- Molecular Biology 87
Countries citing papers authored by Massimo Amelotti
This map shows the geographic impact of Massimo Amelotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Amelotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Amelotti more than expected).
Fields of papers citing papers by Massimo Amelotti
This network shows the impact of papers produced by Massimo Amelotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Amelotti. The network helps show where Massimo Amelotti may publish in the future.
Co-authors
The 12 scholars most cited alongside Massimo Amelotti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 162 | |
| 2 | 2020 | 86 | |
| 3 | 2020 | 56 | |
| 4 | 2003 | 29 | |
| 5 | 1998 | 26 | |
| 6 | 1999 | 10 | |
| 7 | 1999 | 4 | |
| 8 | Monoclonal Lym-1 antibody-targeted lysis of B lymphoma cells by neutrophils. Evidence for two mechanisms of FcgammaRII-dependent cytolysis. | 2000 | 3 |
| 9 | 2000 | 3 |
About Massimo Amelotti
Massimo Amelotti is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging, Infectious Diseases, Physiology and Immunology and Allergy, having authored 9 papers that have together received 379 indexed citations. Recurring topics across this work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), COVID-19 Clinical Research Studies (2 papers), Blood transfusion and management (1 paper), Cell death mechanisms and regulation (1 paper), Immune Cell Function and Interaction (1 paper), Cell Adhesion Molecules Research (1 paper) and Acute Kidney Injury Research (1 paper). The work is most often cited by research in Infectious Diseases (88 citations), Nephrology (40 citations), Immunology (71 citations), Biochemistry (21 citations) and Molecular Biology (87 citations). Massimo Amelotti has collaborated with scholars based in Italy and United States. Frequent co-authors include Franco Dallegri, Luciano Carlo Ottonello, Giuseppe Tortolina, Patrizia Dapino, Maria Bianca Bertolotto, Paola Contini, Clemente Mazzei, Francesco Indiveri, Francesco Puppo and Massimo Ghio. Their work appears in journals such as Inflammation Research, Blood, Clinical Microbiology and Infection, Journal of Leukocyte Biology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.